PSSNY Opposes Cigna-Express Scripts Merger and Resulting Increased Market Concentration

There is a crisis escalating in the U.S. healthcare system as drug prices continue to soar and the largest healthcare corporations respond by consolidating to increase their market share and decrease their competition. Cigna’s announcement of its intent to purchase Express Scripts, the last of the three major pharmacy benefit managers (PBMs) and arguably the largest, should alert the Federal Trade Commission (FTC) and the Food and Drug Administration that something is seriously wrong. 

Read Press Release